口服非肽類胰高血糖素樣肽-1(GLP-1)激動劑,它的優(yōu)勢是非肽類,在胃腸道不容易被分解,可以與食物一起服用。
Orforglipron (LY-3502970) is an oral, non-peptide, small molecule glucagon-like peptide-1 receptor agonist developed as a weight loss drug by Eli Lilly and Company.[1][2] It is easier to produce than current peptide GLP-1 agonists and is expected to be cheaper.[3]
德州佳泰化工科技有限公司
聯(lián)系商家時請?zhí)峒癱hemicalbook,有助于交易順利完成!
德州佳泰